Wezlana Q Code: Q5137

Self-Administered Drug Exclusion 6 Medicare Administrative Contractors list Q5137 as usually self-administered and exclude it from Part B coverage in their jurisdictions. Check the article for your MAC before billing: First Coast, Noridian (A53032), Noridian (A53033), Novitas, Palmetto, Wellpoint Federal, WPS · All SAD lists →

Drug & Product Overview

HCPCS Descriptor Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg

HCPCS Added Date July 1, 2024

Manufacturer Nuvaila

Route of Administration Subcutaneous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Solution

About Wezlana

Wezlana is a medication aligned to the HCPCS Q Code: Q5137 for billing, pricing, and reimbursement purposes in the United States. Classified under Immunology, it is administered via the subcutaneous route and manufactured by Nuvaila.

Manufacturers, reach out to us to add more information.

NDC Code Information

6 NDC packages are crosswalked to Q5137. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	Wezlana
	Wezlana
	Wezlana
	Wezlana

Login to view 6 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Wezlana Pricing & Reimbursement

Q5137 Private Payer Reimbursement

$62.43 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Ustekinumab Biosimilar Information:

Wezlana Approval Date: October 31, 2023

Product Name	HCPCS Code	Active Ingredient	BLA Type
Stelara	J3358	Ustekinumab	351(a) Originator Product
Wezlana	Q5137	Ustekinumab	351(k) Interchangeable
Wezlana	Q5138	Ustekinumab	351(k) Interchangeable
Selarsdi	Q9998	Ustekinumab	351(k) Interchangeable
Pyzchiva	Q9996	Ustekinumab	351(k) Interchangeable
Pyzchiva	Q9997	Ustekinumab	351(k) Interchangeable
Otulfi	Q9999	Ustekinumab	351(k) Interchangeable
Imuldosa	Q5098	Ustekinumab	351(k) Interchangeable
Yesintek	Q5100	Ustekinumab	351(k) Interchangeable
Steqeyma	Q5099	Ustekinumab	351(k) Interchangeable
Starjemza	Q5164	Ustekinumab	351(k) Interchangeable

Wezlana CPT Administration Codes

CPT Code	Description
96372	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

Wezlana Medically Unlikely Edits (MUE)

The most billing units of Q5137 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient

90 units / day

= 90 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

Wezlana Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Crohn's Disease Plaque Psoriasis Psoriatic Arthritis Ulcerative Colitis

Drug Class

Interleukin-12 Antagonist [EPC]Interleukin-12 Antagonists [MoA]Interleukin-23 Antagonist [EPC]Interleukin-23 Antagonists [MoA]

Frequently Asked Questions

Is there an available Wezlana billing and coding guide?

Our team did not identify patient assistance information for Wezlana

Are there any available Wezlana patient assistance programs?

Wezlana patient assistance information can be found through Nuvaila. Visit Here →

Where can I find Wezlana prescribing information?

Wezlana prescribing information can be found at the link below:

Where can I find Wezlana side effect information?

Our team did not identify a source of side effect information for Wezlana.

Does billing Wezlana require JZ/JW wastage modifiers?

CMS does not include Wezlana (Q5137) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing Q5137. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.